P401: INNOVATIVE REDUCED-DOSE CHEMOTHERAPY FOLLOWED BY BLINATUMOMAB INDUCTION THERAPY FOR SUCCESSFUL MANAGEMENT OF TREATMENT NAIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA ADULTS: A MULTICENTER, REAL-WORLD STUDY
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000968512.20949.2b |
_version_ | 1797280128310444032 |
---|---|
author | Jing Lu Huifen Zhou Xin Zhou Yonggong Yang Laigen Tong Miao Miao Xiaofei Yang Suning Chen |
author_facet | Jing Lu Huifen Zhou Xin Zhou Yonggong Yang Laigen Tong Miao Miao Xiaofei Yang Suning Chen |
author_sort | Jing Lu |
collection | DOAJ |
first_indexed | 2024-03-07T16:36:44Z |
format | Article |
id | doaj.art-c6a9bc8f1f45419ab3ca50dbc4ba9672 |
institution | Directory Open Access Journal |
issn | 2572-9241 |
language | English |
last_indexed | 2024-03-07T16:36:44Z |
publishDate | 2023-08-01 |
publisher | Wiley |
record_format | Article |
series | HemaSphere |
spelling | doaj.art-c6a9bc8f1f45419ab3ca50dbc4ba96722024-03-03T09:43:31ZengWileyHemaSphere2572-92412023-08-017e209492b10.1097/01.HS9.0000968512.20949.2b202308003-00302P401: INNOVATIVE REDUCED-DOSE CHEMOTHERAPY FOLLOWED BY BLINATUMOMAB INDUCTION THERAPY FOR SUCCESSFUL MANAGEMENT OF TREATMENT NAIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA ADULTS: A MULTICENTER, REAL-WORLD STUDYJing Lu0Huifen Zhou1Xin Zhou2Yonggong Yang3Laigen Tong4Miao Miao5Xiaofei Yang6Suning Chen71 The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Department of Hematology, Suzhou, China1 The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Department of Hematology, Suzhou, China2 Wuxi People’s Hospital Affiliated to Nanjing Medical University, Department of Hematology, WuXi, China3 The Affiliated Drum Tower Hospital of Nanjing University Medical School, Department of Hematology, Nanjing, China4 Yixing People’s Hospital, The Affiliated Hospital of Jiangsu University, Department of Hematology, Yixing, China1 The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Department of Hematology, Suzhou, China1 The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Department of Hematology, Suzhou, China1 The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Department of Hematology, Suzhou, Chinahttp://journals.lww.com/10.1097/01.HS9.0000968512.20949.2b |
spellingShingle | Jing Lu Huifen Zhou Xin Zhou Yonggong Yang Laigen Tong Miao Miao Xiaofei Yang Suning Chen P401: INNOVATIVE REDUCED-DOSE CHEMOTHERAPY FOLLOWED BY BLINATUMOMAB INDUCTION THERAPY FOR SUCCESSFUL MANAGEMENT OF TREATMENT NAIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA ADULTS: A MULTICENTER, REAL-WORLD STUDY HemaSphere |
title | P401: INNOVATIVE REDUCED-DOSE CHEMOTHERAPY FOLLOWED BY BLINATUMOMAB INDUCTION THERAPY FOR SUCCESSFUL MANAGEMENT OF TREATMENT NAIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA ADULTS: A MULTICENTER, REAL-WORLD STUDY |
title_full | P401: INNOVATIVE REDUCED-DOSE CHEMOTHERAPY FOLLOWED BY BLINATUMOMAB INDUCTION THERAPY FOR SUCCESSFUL MANAGEMENT OF TREATMENT NAIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA ADULTS: A MULTICENTER, REAL-WORLD STUDY |
title_fullStr | P401: INNOVATIVE REDUCED-DOSE CHEMOTHERAPY FOLLOWED BY BLINATUMOMAB INDUCTION THERAPY FOR SUCCESSFUL MANAGEMENT OF TREATMENT NAIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA ADULTS: A MULTICENTER, REAL-WORLD STUDY |
title_full_unstemmed | P401: INNOVATIVE REDUCED-DOSE CHEMOTHERAPY FOLLOWED BY BLINATUMOMAB INDUCTION THERAPY FOR SUCCESSFUL MANAGEMENT OF TREATMENT NAIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA ADULTS: A MULTICENTER, REAL-WORLD STUDY |
title_short | P401: INNOVATIVE REDUCED-DOSE CHEMOTHERAPY FOLLOWED BY BLINATUMOMAB INDUCTION THERAPY FOR SUCCESSFUL MANAGEMENT OF TREATMENT NAIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA ADULTS: A MULTICENTER, REAL-WORLD STUDY |
title_sort | p401 innovative reduced dose chemotherapy followed by blinatumomab induction therapy for successful management of treatment naive b cell acute lymphoblastic leukemia adults a multicenter real world study |
url | http://journals.lww.com/10.1097/01.HS9.0000968512.20949.2b |
work_keys_str_mv | AT jinglu p401innovativereduceddosechemotherapyfollowedbyblinatumomabinductiontherapyforsuccessfulmanagementoftreatmentnaivebcellacutelymphoblasticleukemiaadultsamulticenterrealworldstudy AT huifenzhou p401innovativereduceddosechemotherapyfollowedbyblinatumomabinductiontherapyforsuccessfulmanagementoftreatmentnaivebcellacutelymphoblasticleukemiaadultsamulticenterrealworldstudy AT xinzhou p401innovativereduceddosechemotherapyfollowedbyblinatumomabinductiontherapyforsuccessfulmanagementoftreatmentnaivebcellacutelymphoblasticleukemiaadultsamulticenterrealworldstudy AT yonggongyang p401innovativereduceddosechemotherapyfollowedbyblinatumomabinductiontherapyforsuccessfulmanagementoftreatmentnaivebcellacutelymphoblasticleukemiaadultsamulticenterrealworldstudy AT laigentong p401innovativereduceddosechemotherapyfollowedbyblinatumomabinductiontherapyforsuccessfulmanagementoftreatmentnaivebcellacutelymphoblasticleukemiaadultsamulticenterrealworldstudy AT miaomiao p401innovativereduceddosechemotherapyfollowedbyblinatumomabinductiontherapyforsuccessfulmanagementoftreatmentnaivebcellacutelymphoblasticleukemiaadultsamulticenterrealworldstudy AT xiaofeiyang p401innovativereduceddosechemotherapyfollowedbyblinatumomabinductiontherapyforsuccessfulmanagementoftreatmentnaivebcellacutelymphoblasticleukemiaadultsamulticenterrealworldstudy AT suningchen p401innovativereduceddosechemotherapyfollowedbyblinatumomabinductiontherapyforsuccessfulmanagementoftreatmentnaivebcellacutelymphoblasticleukemiaadultsamulticenterrealworldstudy |